Select a Region

North America

Newscenter

Browsing Archive: ITCITC | EVERSANA

EVERSANA

Posted on 2월 1, 20232/1/23

Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis

EVERSANA

Posted on 2월 1, 20232/1/23

The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis

EVERSANA

Posted on 2월 1, 20232/1/23

The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy

ITC